Alps Advisors Inc Chimerix Inc Transaction History

Alps Advisors Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$5.23 - $7.18 $552,868 - $759,004	-105,711 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.94 - $8.75 $46,557 - $68,582	-7,838 Reduced 6.9%	105,711 $654,000
Q2 2021 Aug 11, 2021	BUY	$7.54 - $9.79 $1,726 - $2,241	229 Added 0.2%	113,549 $908,000
Q1 2021 May 07, 2021	BUY	$4.76 - $11.25 $9,282 - $21,937	1,950 Added 1.75%	113,320 $1.09 Million
Q4 2020 Feb 03, 2021	BUY	$2.43 - $5.42 $143,948 - $321,069	59,238 Added 113.63%	111,370 $538,000
Q2 2018 Jul 25, 2018	SELL	$4.43 - $5.14 $48,583 - $56,370	-10,967 Reduced 17.38%	52,132 $241,000
Q1 2018 May 01, 2018	BUY	$4.65 - $5.9 $50,996 - $64,705	10,967 Added 21.04%	63,099 $328,000
Q4 2017 Feb 05, 2018	BUY	$4.32 - $5.52 $25,060 - $32,021	5,801 Added 12.52%	52,132 $241,000
Q3 2017 Nov 03, 2017	BUY	$4.35 - $5.25 $201,539 - $243,237	46,331	46,331 $243,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.